Analysis Hypertension Diagnostics, Inc. (HDII)
5/29/2024
Analysis of Hypertension Diagnostics, Inc. (HDII)
Hypertension Diagnostics, Inc. (HDII) seems to be trading at a consistent price of $0.00010 over the past few days. The Relative Strength Index (RSI) indicator is extremely low at 1.33813, indicating an oversold condition.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is slightly below the signal line, with a positive MACD histogram. This suggests a potential bullish momentum in the short term.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing a slight decline over the past few days.
Overall, based on the RSI and MACD indicators, there might be a short-term bullish opportunity for HDII. However, further analysis and confirmation from other technical indicators would be recommended before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential challenge in managing production or procurement costs.
3. The gross profit margin has remained relatively stable over the years, indicating that the company has been able to maintain profitability despite the increase in sales and cost of goods sold.
4. Operating income has also shown a positive trend, increasing from $66.3 billion in 2020 to $114.3 billion in 2023, suggesting efficient management of operating expenses.
5. Net income has increased consistently over the years, reaching $97 billion in 2023, indicating overall profitability and effective tax management.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased, reflecting the company's ability to generate value for its shareholders.
7. The company's EBITDA has also increased over the years, indicating improved operational performance and efficiency.
8. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
9. Overall, the financial performance of the company seems to be positive, with a focus on revenue growth, cost management, and profitability.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
6. Investing activities include significant amounts related to the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 from the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecast. Investors should consider these forecasts along with other factors when making investment decisions.
MACD of HDII
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
